NovoCure Ltd (NVCR) stock
NVCRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/3031% below fair value
$10.73−0.41 (-3.68%)
Close on Nov 18, 2026Market cap $1.25BP/E –Yield –
NovoCure market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
NovoCure's market cap was $1.40B on Nov 11, 2026, against $1.43B a year earlier. Over the last 5 years it ranged from $1.23B to $9.57B, with a median of $2.06B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.40B | -3.6% |
| 2025 | Dec 31, 2025 | $1.45B | -55.1% |
| 2024 | Dec 31, 2024 | $3.22B | +102.1% |
| 2023 | Dec 29, 2023 | $1.59B | -79.3% |
| 2022 | Dec 30, 2022 | $7.70B | -1.2% |
| 2021 | Dec 31, 2021 | $7.79B | -55.7% |
| 2020 | Dec 31, 2020 | $17.60B | +111.1% |
| 2019 | Dec 31, 2019 | $8.34B | +167.8% |
| 2018 | Dec 31, 2018 | $3.11B | +72.5% |
| 2017 | Dec 29, 2017 | $1.80B | +168.1% |
| 2016 | Dec 30, 2016 | $673.34M | +142.2% |
| 2015 | Dec 31, 2015 | $277.99M | – |
See a number that looks wrong?